Newron Pharmaceuticals Stock Forward View - Accumulation Distribution
| NWRN Stock | CHF 19.76 0.39 1.94% |
Newron Stock outlook is based on your current time horizon.
At this time the rsi of Newron Pharmaceuticals' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Current Year (0.67) | EPS Estimate Next Year (0.50) | Wall Street Target Price 40.3129 | Quarterly Revenue Growth 2.492 |
Using Newron Pharmaceuticals hype-based prediction, you can estimate the value of Newron Pharmaceuticals SpA from the perspective of Newron Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Newron Pharmaceuticals after-hype prediction price | CHF 20.35 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Newron |
Newron Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Newron price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Newron using various technical indicators. When you analyze Newron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 7577.79 | 4456.53 |
| Check Newron Pharmaceuticals Volatility | Backtest Newron Pharmaceuticals | Information Ratio |
Newron Pharmaceuticals Trading Date Momentum
| On February 04 2026 Newron Pharmaceuticals SpA was traded for 19.76 at the closing time. The highest price during the trading period was 20.45 and the lowest recorded bid was listed for 19.58 . The volume for the day was 104.8 K. This history from February 4, 2026 did not cause price change. The trading delta at closing time to the current price is 1.01% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Newron Pharmaceuticals to competition |
Other Forecasting Options for Newron Pharmaceuticals
For every potential investor in Newron, whether a beginner or expert, Newron Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Newron Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Newron. Basic forecasting techniques help filter out the noise by identifying Newron Pharmaceuticals' price trends.Newron Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Newron Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Newron Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Newron Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Newron Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Newron Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Newron Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Newron Pharmaceuticals stock market strength indicators, traders can identify Newron Pharmaceuticals SpA entry and exit signals to maximize returns.
| Accumulation Distribution | 4456.53 | |||
| Daily Balance Of Power | (0.45) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 20.02 | |||
| Day Typical Price | 19.93 | |||
| Price Action Indicator | (0.45) | |||
| Period Momentum Indicator | (0.39) |
Newron Pharmaceuticals Risk Indicators
The analysis of Newron Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Newron Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting newron stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.08 | |||
| Semi Deviation | 2.79 | |||
| Standard Deviation | 3.98 | |||
| Variance | 15.87 | |||
| Downside Variance | 10.29 | |||
| Semi Variance | 7.8 | |||
| Expected Short fall | (3.86) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Newron Pharmaceuticals
The number of cover stories for Newron Pharmaceuticals depends on current market conditions and Newron Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Newron Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Newron Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Newron Pharmaceuticals Short Properties
Newron Pharmaceuticals' future price predictability will typically decrease when Newron Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Newron Pharmaceuticals SpA often depends not only on the future outlook of the potential Newron Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Newron Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.6 M | |
| Cash And Short Term Investments | 9.8 M |
Additional Tools for Newron Stock Analysis
When running Newron Pharmaceuticals' price analysis, check to measure Newron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Newron Pharmaceuticals is operating at the current time. Most of Newron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Newron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Newron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Newron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.